Sun Pharmaceutical Industries has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration (FDA). CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye)
...read more
The announcement was made before market hours today, 16 August 2018.
Meanwhile, the S&P BSE Sensex was down 26.74 points, or 0.07% to 37,825.26
On the BSE, 6.71 lakh shares ...read more
The result was announced during market hours today, 14 August 2018.
Meanwhile, the S&P BSE Sensex was up 222.59 points, or 0.59% to 37,867.49
On the BSE, 16.66 lakh shares w...read more
